No images? Click here MEDICAL ADVISORY: Two New COVID-19 Administration RecommendationsIssued by: M. Mustafa Hirji, MD, MPH, FRCPC, Medical Officer of Health & Commissioner (Acting) Effective immediately, the National Advisory Committee on Immunization (NACI) and the Ministry of Health have issued two recommendations regarding the administration of COVID-19 vaccines. Recommendation #1: Concomitant Administration of COVID-19 Vaccine with other Vaccines On September 28, 2021, the National Advisory Committee on Immunization (NACI) released an updated recommendation on the timing of COVID-19 and non-COVID vaccines administration. NACI Recommendation NACI recommends that COVID-19 vaccines may be given at the same time as, or any time before or after, other vaccines, including live, non-live, adjuvanted or unadjuvanted vaccines. Additional Information on Recommendation
Recommendation #2: Preferential Use of Pfizer for Individuals 12-24 years Out of an abundance of caution, the Ministry of Health is issuing a preferential recommendation of the use of Pfizer-BioNTech vaccine (Cominarty) for individuals aged 12-24 years old. Effective immediately, Pfizer-BioNTech COVID-19 Vaccine (Cominarty) is the preferred vaccine for individuals under 25 years of age. However, Moderna’s Spikevax COVID-19 vaccine remains licensed by Health Canada as safe and effective to use in this population if that is patient preference, or if only Moderna’s vaccine is available. Rationale This recommendation is based on an observed increase in Ontario of myocarditis/pericarditis following vaccination with Moderna’s Spikevax compared to Pfizer-BioNTech’s Cominarty in the 18 to 24 year age group, particularly among males. Additional Information on Recommendation
More Information
|